Path: Home > YY/T > Page1 > YY/T 0576-2024

Price & Delivery

US$199.00 · In stock · Download in 9 seconds
YY/T 0576-2024: Columbia blood agar medium
Delivery: 9 seconds. True-PDF full-copy in English & invoice will be downloaded + auto-delivered via email. See step-by-step procedure
Status: Valid

Std ID	Version	USD	Buy	Deliver [PDF] in	Title (Description)
YY/T 0576-2024	English	199	Add to Cart	3 days [Need to translate]	Columbia blood agar medium
YY/T 0576-2005	English	219	Add to Cart	3 days [Need to translate]	Columbia blood agar base medium

YY/T 0576-2024: Columbia blood agar medium

---This is a DRAFT version for illustration, not a final translation. Full copy of true-PDF in English version (including equations, symbols, images, flow-chart, tables, and figures etc.) will be manually/carefully translated upon your order.
ICS 11.100.10 CCSC44 Pharmaceutical Industry Standards of the People's Republic of China Replaces YY/T 0576-2005 Columbia blood agar Released on 2024-09-29 Implementation on October 15, 2025 The State Drug Administration issued

Foreword

This document is in accordance with the provisions of GB/T 1.1-2020 "Guidelines for standardization work Part 1.Structure and drafting rules for standardization documents" Drafting. This document replaces YY/T 0576-2005 Columbia Blood Agar Medium. Compared with YY/T 0576-2005, except for the structural adjustment In addition to editorial changes, the main technical changes are as follows. --- Changed the scope of the standard (see Chapter 1, Chapter 1 of the.2005 edition); --- Changed the "culture medium" in the terms and definitions (see Chapter 3, Chapter 3 of the.2005 edition); --- Added "4.2 Preparation Method" (see Chapter 4); ---Changed "loss on drying" to "water content", added appearance, thickness, pH, microbial limit and growth in "plate culture medium" The performance index requirements of the test have been expanded to include the “stability” performance index requirements (see Chapter 5, Chapter 5 of the.2005 edition); --- The test method has been changed (see Chapter 6, Chapter 6 of the.2005 edition); --- Deleted "Instructions for Use" (see Chapter 7 of the.2005 edition); --- Changed the signs and labels (see Chapter 7, Chapter 8 of the.2005 edition); --- Changed packaging, transportation and storage (see Chapter 8, Chapter 9 of the.2005 edition); --- Columbia blood agar growth test (see Appendix A, Appendix A of the.2005 edition) has been changed. Please note that some of the contents of this document may involve patents. The issuing organization of this document does not assume the responsibility for identifying patents. This document is proposed by the State Food and Drug Administration. This document is under the jurisdiction of the National Technical Committee for Standardization of Medical Clinical Testing Laboratories and In Vitro Diagnostic Systems (SAC/TC136). This document was drafted by. China Food and Drug Inspection Institute, Henan Provincial Drug and Medical Device Inspection Institute (Henan Provincial Vaccine Approval Center), Shanghai Institute of Medical Device Inspection, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Zhengzhou Antu Bioengineering Co., Ltd., Zhengzhou Bo Sai Biotechnology Co., Ltd., Zhongxiu Technology Co., Ltd., Qingdao High-tech Industrial Park Haibo Biotechnology Co., Ltd., Beijing San Pharmaceutical Technology Co., Ltd. The main drafters of this document are. Yu Ting, Li Fengchun, Deng Min, Yi Qiaolian, Yang Yongkang, Ding Kunfeng, Tan Weili, Cai Xiangrong, Wang Jinheng, Bao Xueyin, Zhang Caiyu, Qu Shoufang, Sun Nan, Hu Zebin, Jia Zheng, Zhang Juanli, Li Guilin, and Zhang Xiaoguo. The previous versions of this document and the documents it replaces are as follows. ---First published in.2005 as YY/T 0576-2005; ---This is the first revision. Columbia blood agar

1 Scope

This document specifies the main components and preparation, requirements, identification, labeling and instructions for use, packaging, transportation, etc. of Columbia blood agar medium. and storage, and describes the corresponding test methods. This document applies to Columbia blood agar culture medium, including dry powder culture medium and plate culture medium.

2 Normative references

The contents of the following documents constitute the essential clauses of this document through normative references in this document. For referenced documents without a date, only the version corresponding to that date applies to this document; for referenced documents without a date, the latest version (including all amendments) applies to This document. GB/T 191 Pictorial markings for packaging, storage and transportation GB/T 29791.2 Information provided by the manufacturer of in vitro diagnostic medical devices (labeling) Part 2.Professional in vitro diagnostic reagents JJF1070-2023 Rules for the measurement and inspection of the net content of quantitatively packaged goods Pharmacopoeia of the People's Republic of China

3 Terms and definitions

The following terms and definitions apply to this document. 3.1 culture medium Prepared by artificial methods, containing natural and/or synthetic ingredients, for the cultivation, separation, identification, research and preservation of microorganisms Liquid, semi-solid or solid mixed nutrient products. 3.2 Quality control strain quality control strain Microorganisms used for quality control and performance testing of culture media. 3.3 colony forming unit; CFU In the counting of live bacteria culture, the colonies formed by the growth and reproduction of a single bacterium or multiple bacterium clusters on a solid culture medium are called It expresses the number of viable bacteria. 4 Main ingredients and preparation method (applicable to dry powder culture medium) 4.1 Main ingredients Trypticase or tryptone 10.0g Beef heart powder 3.0g Corn starch 1.0g Peptone 5.0g ...